July Blood Cancer Highlights: Top 5 Updates Patients Should Know
As July concludes, the landscape of hematologic oncology continues to evolve, with notable progress in multiple myeloma, myelofibrosis, and CLL.
As July concludes, the landscape of hematologic oncology continues to evolve, with notable progress in multiple myeloma, myelofibrosis, and CLL.
Support and research for epithelioid hemangioendothelioma are growing, with the EHE Foundation helping connect patients to expert care and resources.
An artificial intelligence-based image analysis model has more accurately predicted cancer biomarkers and outcomes compared with conventional methods.
Follicular lymphoma survivor Troy Anderson credited acupuncture and nutrition guidance with easing treatment side effects and aided in remission.
Among patients with advanced gastrointestinal stromal tumors, Gleevec and Mektovi was associated with benefits in progression and survival.
When I was diagnosed with peritoneal mesothelioma at 21 years old, the doctors gave me 18 months to live; that was 18 years ago.
About one in six men with grade group 1 prostate cancer have higher-risk disease, showing outcomes vary and biopsy grade may underestimate risk.
The Royal College of Nursing is among 14 signatories of a letter to NHS England boss Sir Jim Mackey on corridor care.
The head of the national body set up to facilitate speaking out by staff about concerns and care failings is to step down, in the…
A university in the South East of England has been given permission to train registered midwives for the first time in years, after its course…
A university in the South East of England has been given permission to train registered midwives for the first time in years, after its course…